ESR1 and breast cancer: Conversely, treatment of ER+ breast cancer cells with a small peptide that increased Cx43 activity decreased breast cancer cell proliferation and improved sensitivity to tamoxifen44, and Cx43 expression correlated with a good prognosis45.